Risks of Personal Information Leakage and Unauthorized Use
First written in FY2021. 4 of 5 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 19 of 80 companies on the "Worse" side.
128 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Because the group obtains highly confidential personal information when storing umbilical cord blood, it endeavors to manage the personal information obtained under the PrivacyMark (MEDIS) system for the health, medical and welfare sectors, which imposes stricter requirements than the Japanese Industrial Standard JIS Q 15001 Personal Information Protection Management Systems—Requirements.」
The risk of personal information leakage and misuse, and the management policy based on the MEDIS system, continue to be maintained. - FY2025RestatedAnnual report
「The company endeavors to manage the personal information obtained under the PrivacyMark (MEDIS) system for the health, medical and welfare sectors, which imposes stricter requirements than the Japanese Industrial Standard JIS Q 15001 Personal Information Protection Management Systems—Requirements.」
The company continues to address the risk of personal information leakage or misuse through management under the MEDIS system. - FY2023RestatedAnnual report
「The company endeavors to manage the personal information obtained under the PrivacyMark (MEDIS) system for the health, medical and welfare sectors, which imposes stricter requirements than the Japanese Industrial Standard JIS Q 15001 Personal Information Protection Management Systems—Requirements.」
The company continues to manage personal information under the MEDIS system. - FY2022RestatedAnnual report
「Because the company obtains highly confidential personal information when storing umbilical cord blood, it endeavors to manage the personal information obtained under the PrivacyMark (MEDIS) system for the health, medical and welfare sectors, which imposes stricter requirements than the Japanese Industrial Standard JIS Q 15001 Personal Information Protection Management Systems—Requirements.」
The company continues to manage personal information under the MEDIS system. No new developments concerning the risk of an impact on the business or performance in the event of leakage or misuse have been reported. - FY2021First statedAnnual report
「Because the company obtains highly confidential personal information when storing umbilical cord blood, it endeavors to manage the personal information obtained under the PrivacyMark (MEDIS) system for the health, medical and welfare sectors, which imposes stricter requirements than the Japanese Industrial Standard JIS Q 15001 Personal Information Protection Management Systems—Requirements. However, if personal information were leaked or misused for any reason, the company's business and performance could be affected by a decline in public trust and the payment of damages, potentially making it difficult to continue operating.」
The company identifies management of personal information under the MEDIS system as a countermeasure.